BioCentury
ARTICLE | Company News

Management tracks

April 14, 2015 2:25 AM UTC

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) hired Ramona Sequeira as president of its U.S. business unit. She succeeds Doug Cole, who stepped down March 31. Sequeira was VP of Lilly USA at Eli Lilly and Co. (NYSE:LLY).

Oncology company Blend Therapeutics Inc. (Watertown, Mass.) named Drew Fromkin president, CEO and director. Fromkin was president and CEO of Clinical Data Inc., which Forest Laboratories Inc. acquired. ...